FdaApplication
ANDA 202179
Identifiers
- fda_app_no: ANDA202179
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | ANDA |
| approval_date | 2013-04-10 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PREDNISOLONE SODIUM PHOSPHATE | PREDNISOLONE SODIUM PHOSPHATE | EQ 15MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
| PREDNISOLONE SODIUM PHOSPHATE | PREDNISOLONE SODIUM PHOSPHATE | EQ 30MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
| PREDNISOLONE SODIUM PHOSPHATE | PREDNISOLONE SODIUM PHOSPHATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
3 products